PN
Prafulla Namdeorao Karpe
About Prafulla Namdeorao Karpe
Data last updated:
Prafulla Namdeorao Karpe is a Director at Morphosis Laboratories Private Limited (since 2022). The companies operate in Chemicals and Pharma. Morphosis Laboratories Private Limited reported revenue of ₹7.1 Lakh (FY 2025). Earlier, Prafulla Namdeorao Karpe was a Whole-Time Director at Knight Pharmaceuticals Private Limited (2002–2019) and Director at Morrison And Boyd Labs Private Limited (from 2012) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Morphosis Laboratories Private Limited U24239MH2022PTC375548 | Director | 27 Jan 2022 | 2022 | ₹7.1 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Knight Pharmaceuticals Private Limited U51397MH2002PTC134531 | Whole-Time Director | 11 Jan 2002 | 2002 | ₹2.09 Cr (FY 2025) | Active |
| Morrison And Boyd Labs Private Limited U24230MH2012PTC231126 | Director | 16 May 2012 | 2012 | Strike Off | |
| Galon Labs Private Limited U51109MH2011PTC214197 | Director | 01 Mar 2011 | 2011 | Strike Off | |
| Morphosis Labs Private Limited U85195MH2006PTC161685 | Director | 08 May 2006 | 2006 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Prafulla Namdeorao Karpe
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anita Prafulla Karpe | 01932392 | Morphosis Laboratories Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Prafulla Namdeorao Karpe
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prafulla Namdeorao Karpe
Prafulla Namdeorao Karpe currently holds 1 directorship: Morphosis Laboratories Private Limited (Director, since 27 Jan 2022, revenue ₹7.1 Lakh (FY 2025)).
Prafulla Namdeorao Karpe was first appointed on 11 Jan 2002 as Whole-Time Director at Knight Pharmaceuticals Private Limited. The most recent appointment on record is 27 Jan 2022 at Morphosis Laboratories Private Limited.
Prafulla Namdeorao Karpe held 4 earlier board appointments: Knight Pharmaceuticals Private Limited (Whole-Time Director, 11 Jan 2002 to 10 Apr 2019); Morrison And Boyd Labs Private Limited (Director, from 16 May 2012); Galon Labs Private Limited (Director, from 01 Mar 2011); Morphosis Labs Private Limited (Director, from 08 May 2006).
The current boards of Prafulla Namdeorao Karpe's companies include Anita Prafulla Karpe (Morphosis Laboratories Private Limited).